Madison Aggregate Bond ETF (MAGG)
- Previous Close
19.81 - Open
19.83 - Bid 19.82 x 1300
- Ask 19.85 x --
- Day's Range
19.83 - 19.85 - 52 Week Range
19.31 - 20.78 - Volume
871 - Avg. Volume
3,128 - Net Assets 52.99M
- NAV 19.79
- PE Ratio (TTM) --
- Yield --
- YTD Daily Total Return -2.76%
- Beta (5Y Monthly) 0.00
- Expense Ratio (net) 0.40%
Under normal market conditions, the fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in bonds. The fund may invest up to 10% of its net assets in shares of other registered investment companies that principally invest in fixed income securities.
Madison Asset Management, LLC
Fund Family
Intermediate Core Bond
Fund Category
52.99M
Net Assets
2023-08-28
Inception Date
Performance Overview: MAGG
Trailing returns as of 4/26/2024. Category is Intermediate Core Bond.
People Also Watch
Recent News: MAGG
Research Reports: MAGG
Daily – Vickers Top Buyers & Sellers for 02/07/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Analyst Report: Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
RatingPrice TargetBB: What does Argus have to say about BB?
BLACKBERRY LTD has an Investment Rating of SELL; a target price of $3.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetBB: What does Argus have to say about BB?
BLACKBERRY LTD has an Investment Rating of SELL; a target price of $3.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target